Covered recipient · General Payments record
FRANKLIN E ELLENSON
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$1,994.54
- Reported across 99 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $706.64 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EMD Serono, Inc. | $132.16 | 5 |
| Lundbeck LLC | $123.94 | 7 |
| EISAI INC. | $74.05 | 2 |
| TG THERAPEUTICS, INC. | $55.77 | 2 |
| PFIZER INC. | $53.41 | 3 |
| ABBVIE INC. | $48.15 | 2 |
| Genentech USA, Inc. | $38.23 | 2 |
| JAZZ PHARMACEUTICALS INC. | $32.52 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.37 | 1 |
| ACADIA Pharmaceuticals Inc | $23.46 | 1 |
| CSL Behring | $21.43 | 1 |
| Neurelis, Inc. | $19.85 | 1 |
| UCB, Inc. | $18.06 | 1 |
| Teva Pharmaceuticals USA, Inc. | $17.83 | 1 |
| Alnylam Pharmaceuticals Inc. | $17.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.87 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103686876 | CMS |
| ABBVIE INC. | $23.28 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103686878 | CMS |
| ACADIA Pharmaceuticals Inc | $23.46 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147968616 | CMS |
| Alnylam Pharmaceuticals Inc. | $17.41 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125847410 | CMS |
| CSL Behring | $21.43 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134665227 | CMS |
| Eisai Inc. | $24.86 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110745842 | CMS |
| Eisai Inc. | $49.19 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110745840 | CMS |
| EMD Serono, Inc. | $35.00 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120212154 | CMS |
| EMD Serono, Inc. | $19.47 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120212156 | CMS |
| EMD Serono, Inc. | $36.84 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120242277 | CMS |
| EMD Serono, Inc. | $25.55 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120247403 | CMS |
| EMD Serono, Inc. | $15.30 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120217672 | CMS |
| Genentech USA, Inc. | $17.92 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133012318 | CMS |
| Genentech USA, Inc. | $20.31 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133012322 | CMS |
| JAZZ PHARMACEUTICALS INC. | $18.00 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150231925 | CMS |
| JAZZ PHARMACEUTICALS INC. | $14.52 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150231927 | CMS |
| Lundbeck LLC | $18.70 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145913331 | CMS |
| Lundbeck LLC | $13.64 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145913333 | CMS |
| Lundbeck LLC | $16.00 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145913335 | CMS |
| Lundbeck LLC | $20.69 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145913337 | CMS |
| Lundbeck LLC | $16.67 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145913339 | CMS |
| Lundbeck LLC | $15.82 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145913341 | CMS |
| Lundbeck LLC | $22.42 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145913343 | CMS |
| Neurelis, Inc. | $19.85 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145640770 | CMS |
| PFIZER INC. | $18.05 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130996825 | CMS |
| PFIZER INC. | $18.15 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131256593 | CMS |
| PFIZER INC. | $17.21 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131319471 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.37 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137539411 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.83 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151636211 | CMS |
| TG Therapeutics, Inc. | $24.21 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136875302 | CMS |
| TG Therapeutics, Inc. | $31.56 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136875398 | CMS |
| UCB, Inc. | $18.06 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143483256 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.